News
Topics
Research & Development
【Conference presentation】Presenting the AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases
Sysmex Corporation presented the latest data on the development of blood-based biomarkers for Alzheimer's Disease at Alzheimer's Disease Annual Meeting to be held from March 28, 2023 to April 1 in Gothenburg, Sweden, " AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases "
Please refer to the following for details.
Academic Report: https://www.sysmex.co.jp/en/rd/report/index.html
| Session | Subject | Presenter (Affiliation) |
|
Oral:
SYMPOSIUM:
FLUID BIOMARKERS, IMAGING (OO095) |
Effects of combined pre-analytical sample handling variables on plasma β-amyloid level measured using a fully automated immunoassay system.
|
Kazuto Yamashita （SYSMEX） |
|
ON-DEMAND
SYMPOSIUM:
FLUID BIOMARKERS 03 (OD322)＊
|
Development of plasma p-tau231 assay on a fully automated immunoassay system.
|
Kengo Ishiki （SYSMEX） |
| Terminology | ||
| ＊ | Joint announcement with Sysmex Corporation, Sysmex R&D Center Americas and ADx NeuroSciences | |
- Information contained in the topics is current as of the date of the announcement,
but may be subject to change without prior notice.